• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pim-1激酶通过与SOCS1和SOCS3相互作用来抑制STAT5依赖性转录。

Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3.

作者信息

Peltola Katriina J, Paukku Kirsi, Aho Teija L T, Ruuska Marja, Silvennoinen Olli, Koskinen Päivi J

机构信息

Turku Centre for Biotechnology, University of Turku/Abo Akademi University, Turku, Finland.

出版信息

Blood. 2004 May 15;103(10):3744-50. doi: 10.1182/blood-2003-09-3126. Epub 2004 Feb 5.

DOI:10.1182/blood-2003-09-3126
PMID:14764533
Abstract

Signal transducer and activator of transcription 5 (STAT5) plays a critical role in cytokine-induced survival of hematopoietic cells. One of the STAT5 target genes is pim-1, which encodes an oncogenic serine/threonine kinase. Here we demonstrate that Pim-1 inhibits STAT5-dependent transcription in cells responsive to interleukin-3, prolactin, or erythropoietin. Ectopic expression of Pim-1 in cytokine-dependent FDCP1 myeloid cells results in reduced tyrosine phosphorylation and DNA binding of STAT5, indicating that Pim-1 interferes already with the initial steps of STAT5 activation. However, the Pim-1 kinase does not directly phosphorylate or bind to STAT5. By contrast, Pim-1 interacts with suppressor of cytokine signaling 1 (SOCS1) and SOCS3 and potentiates their inhibitory effects on STAT5, most likely via phosphorylation-mediated stabilization of the SOCS proteins. Thus, both Pim and SOCS family proteins may be components of a negative feedback mechanism that allows STAT5 to attenuate its own activity.

摘要

信号转导及转录激活因子5(STAT5)在细胞因子诱导的造血细胞存活中起关键作用。STAT5的靶基因之一是pim-1,其编码一种致癌性丝氨酸/苏氨酸激酶。在此我们证明,Pim-1在对白介素-3、催乳素或促红细胞生成素产生应答的细胞中抑制STAT5依赖性转录。在细胞因子依赖性FDCP1髓样细胞中异位表达Pim-1会导致STAT5的酪氨酸磷酸化和DNA结合减少,这表明Pim-1已经在干扰STAT5激活的初始步骤。然而,Pim-1激酶并不直接磷酸化或结合STAT5。相反,Pim-1与细胞因子信号转导抑制因子1(SOCS1)和SOCS3相互作用,并增强它们对STAT5的抑制作用,最有可能是通过磷酸化介导的SOCS蛋白稳定化。因此,Pim和SOCS家族蛋白可能都是负反馈机制的组成部分,该机制使STAT5能够减弱其自身活性。

相似文献

1
Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3.Pim-1激酶通过与SOCS1和SOCS3相互作用来抑制STAT5依赖性转录。
Blood. 2004 May 15;103(10):3744-50. doi: 10.1182/blood-2003-09-3126. Epub 2004 Feb 5.
2
Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin.原癌蛋白GFI-1B对Socs基因表达的调控:促红细胞生成素诱导STAT5靶基因的两条途径。
J Biol Chem. 2002 Jan 18;277(3):2345-52. doi: 10.1074/jbc.M105575200. Epub 2001 Nov 5.
3
Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.细胞因子信号转导抑制因子(SOCS)蛋白的不同活性以及SOCS盒在控制粒细胞集落刺激因子(G-CSF)信号转导中的作用。
J Leukoc Biol. 2004 Jul;76(1):237-44. doi: 10.1189/jlb.0104041. Epub 2004 Apr 23.
4
Pim serine/threonine kinases regulate the stability of Socs-1 protein.Pim丝氨酸/苏氨酸激酶调节Socs-1蛋白的稳定性。
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2175-80. doi: 10.1073/pnas.042035699.
5
Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.内质网应激延长生长激素诱导的Janus激酶2(JAK2)/信号转导子和转录激活子5(STAT5)信号通路。
Mol Endocrinol. 2001 Sep;15(9):1471-83. doi: 10.1210/mend.15.9.0699.
6
Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation.Pim-1的表达足以使小鼠造血细胞不依赖细胞因子,但对于BCR-ABL介导的转化并非必需。
Exp Hematol. 2002 Jul;30(7):697-702. doi: 10.1016/s0301-472x(02)00808-1.
7
STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5.信号转导和转录的关键介质——信号转导及转录激活蛋白:从信号转导及转录激活蛋白5中获得的经验教训
Cytokine Growth Factor Rev. 2004 Dec;15(6):435-55. doi: 10.1016/j.cytogfr.2004.09.001.
8
G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.在严重先天性中性粒细胞减少症/急性髓系白血病中发现的粒细胞集落刺激因子受体截短可缓解细胞因子信号传导抑制因子3对信号转导和转录激活因子5的控制抑制作用,但对信号转导和转录激活因子3的抑制作用保持不变。
Blood. 2004 Aug 1;104(3):667-74. doi: 10.1182/blood-2003-08-2913. Epub 2004 Apr 6.
9
Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.酪氨酸磷酸化的SOCS-3抑制信号转导和转录激活因子(STAT)的激活,但能与p120 RasGAP结合并激活Ras。
Nat Cell Biol. 2001 May;3(5):460-5. doi: 10.1038/35074525.
10
STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.STAT5作为造血细胞增殖、分化和凋亡的分子调节因子。
EMBO J. 1999 Sep 1;18(17):4754-65. doi: 10.1093/emboj/18.17.4754.

引用本文的文献

1
Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to Immunotherapy.抑制肿瘤相关巨噬细胞中的PIM激酶可抑制炎性小体激活并使前列腺癌对免疫疗法敏感。
Cancer Immunol Res. 2025 May 2;13(5):633-645. doi: 10.1158/2326-6066.CIR-24-0591.
2
PIM1 kinase and its diverse substrate in solid tumors.PIM1 激酶及其在实体瘤中的多种底物。
Cell Commun Signal. 2024 Nov 1;22(1):529. doi: 10.1186/s12964-024-01898-y.
3
PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target.
PIM1 信号在免疫炎症性疾病中的作用:一个新兴的治疗靶点。
Front Immunol. 2024 Sep 20;15:1443784. doi: 10.3389/fimmu.2024.1443784. eCollection 2024.
4
Zfp36l1 establishes the high-affinity CD8 T-cell response by directly linking TCR affinity to cytokine sensing.Zfp36l1 通过将 TCR 亲和力与细胞因子感应直接联系起来,建立了高亲和力的 CD8 T 细胞反应。
Eur J Immunol. 2024 Feb;54(2):e2350700. doi: 10.1002/eji.202350700. Epub 2023 Dec 7.
5
PIM kinases regulate early human Th17 cell differentiation.PIM 激酶调节早期人类 Th17 细胞分化。
Cell Rep. 2023 Dec 26;42(12):113469. doi: 10.1016/j.celrep.2023.113469. Epub 2023 Nov 30.
6
An atlas of genetic scores to predict multi-omic traits.遗传评分图谱预测多组学特征
Nature. 2023 Apr;616(7955):123-131. doi: 10.1038/s41586-023-05844-9. Epub 2023 Mar 29.
7
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo.一种选择性的小分子 STAT5 PROTAC 降解剂,能够在体内实现肿瘤消退。
Nat Chem Biol. 2023 Jun;19(6):703-711. doi: 10.1038/s41589-022-01248-4. Epub 2023 Feb 2.
8
Targeting Pim kinases in hematological cancers: molecular and clinical review.靶向血液系统恶性肿瘤的 Pim 激酶:分子与临床综述。
Mol Cancer. 2023 Jan 25;22(1):18. doi: 10.1186/s12943-023-01721-1.
9
The Role of PIM Kinases in Pediatric Solid Tumors.PIM激酶在儿童实体瘤中的作用。
Cancers (Basel). 2022 Jul 22;14(15):3565. doi: 10.3390/cancers14153565.
10
PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer.PIM1/STAT3 轴:三阴性乳腺癌的潜在联合治疗靶点。
Med Oncol. 2022 May 15;39(5):74. doi: 10.1007/s12032-022-01675-2.